{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-006940","form_type":"8-K","ticker":null,"cik":"0000874710","company_name":"ALLIED HEALTHCARE PRODUCTS INC","filed_at":"2023-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.337698+00:00","generated_at":"2026-06-20T08:53:38.567943+00:00","sec_items":["2.05","2.06","3.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Allied Healthcare approves asset disposal; Nasdaq delisting effective Feb 3","bullets":["Board approved plan to dispose of all or substantially all assets; Morris Anderson engaged to manage sale.","Estimated $17.5M multiemployer pension withdrawal liability from prior reduction in force.","Other liabilities: $865K loan from North Mill Capital and $14.7M rent due on lease through remaining term.","Nasdaq delisting due to failure to file Q3 Form 10-Q and no compliance plan; delisting effective Feb 3, 2023.","2022 Annual Meeting of Stockholders postponed indefinitely."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-006940","json":"https://secwatch.observer/filing/0001104659-23-006940.json","markdown":"https://secwatch.observer/filing/0001104659-23-006940.md","text":"https://secwatch.observer/filing/0001104659-23-006940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/874710/000110465923006940/0001104659-23-006940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/874710/000110465923006940/tm234514d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T08:53:38.567943+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b31f9c74a6ac8f1c2de178ee104095bfb0b2f6f0","claim":"ALLIED HEALTHCARE PRODUCTS INC received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"January 25, 2023, Nasdaq notified the Company that, because of the Company’s failure to submit a compliance plan and its inability to file the late quarterly report, it has determined to delist the stock. The Company does not intend to appeal this decision and the delisting is expected to be effective at the opening of business on February 3, 2023, at which time trading in the Company’s stock will be suspended.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/874710/000110465923006940/0001104659-23-006940-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}